Get our introductory offer at only
*$0.99/month for first 3 months
$29.90/month for the next 9 months
TEMASEK Holdings can stay the course with its poor performers because it invests for the long term.
The point was made at Temasek's annual review on Tuesday, after shares of German life science giant Bayer had fallen by 39 per cent since...